WONBQGAOOBPRRK-MHZLTWQESA-N
C32H29ClF6N8O — CID 134212363
Data last refreshed: (MolForge compound catalog, from PubChem)
About WONBQGAOOBPRRK-MHZLTWQESA-N
WONBQGAOOBPRRK-MHZLTWQESA-N (PubChem CID 134212363) has the molecular formula C32H29ClF6N8O and a molecular weight of 691.08 g/mol. Its IUPAC name is 8-chloro-6-[[(S)-(2-methyl-1-oxoisoquinolin-5-yl)-[3-[1-(trifluoromethyl)cyclopropyl]-1,2-dihydrotriazol-5-yl]methyl]amino]-4-[(3,3,3-trifluoro-2,2-dimethylpropyl)amino]quinoline-3-carbonitrile.
Molecular Properties
| Compound Name | WONBQGAOOBPRRK-MHZLTWQESA-N |
|---|---|
| PubChem CID | 134212363 |
| Molecular Formula | C32H29ClF6N8O |
| Molecular Weight | 691.08 g/mol |
| Exact Mass | 690.21 |
| IUPAC Name | 8-chloro-6-[[(S)-(2-methyl-1-oxoisoquinolin-5-yl)-[3-[1-(trifluoromethyl)cyclopropyl]-1,2-dihydrotriazol-5-yl]methyl]amino]-4-[(3,3,3-trifluoro-2,2-dimethylpropyl)amino]quinoline-3-carbonitrile |
| SMILES | Cn1ccc2c([C@H](Nc3cc(Cl)c4ncc(C#N)c(NCC(C)(C)C(F)(F)F)c4c3)C3=CN(C4(C(F)(F)F)CC4)NN3)cccc2c1=O |
| InChI | InChI=1S/C32H29ClF6N8O/c1-29(2,31(34,35)36)16-42-25-17(13-40)14-41-26-22(25)11-18(12-23(26)33)43-27(20-5-4-6-21-19(20)7-10-46(3)28(21)48)24-15-47(45-44-24)30(8-9-30)32(37,38)39/h4-7,10-12,14-15,27,43-45H,8-9,16H2,1-3H3,(H,41,42)/t27-/m0/s1 |
| InChIKey | WONBQGAOOBPRRK-MHZLTWQESA-N |
| XLogP | 7.03 |
| TPSA | 110.04 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 48 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 691.08 |
| LogP ≤ 5 | 7.03 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 9 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 134212363 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.